SCHEMBL17718569

SCHEMBL17718569

COc1cc(-c2nnc(NC(=O)c3ccc(S(=O)(=O)N(C)c4ccccc4)cc3)o2)cc(OC)c1OC

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 12/20 0.69
▸ KMT2A Q03164 12/20 0.69
▸ LMNA P02545 12/20 0.69
▸ MEN1 O00255 11/20 0.69
▸ TDP1 Q9NUW8 9/20 0.69
▸ TP53 P04637 8/20 0.69
▸ USP2 O75604 3/20 0.69
▸ HTT P42858 11/20 0.64
▸ KDM4E B2RXH2 10/20 0.64
▸ MAPT P10636 3/20 0.64
▸ ALDH1A1 P00352 2/20 0.63
▸ ALOX15 P16050 5/20 0.62
▸ RECQL P46063 1/20 0.62
▸ HPGD P15428 2/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ CRHBP P24387 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ CRHR2 Q13324 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15572240 0.89 MEN1 (0.72) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17716978 0.86 KDM4E (0.84) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17716979 0.86 MEN1 (0.75) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17716952 0.86 MEN1 (0.75) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17719217 0.85 KMT2A (0.63) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17718572 0.83 KDM4E (0.66) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL21464976 0.80 MEN1 (0.82) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17719214 0.79 KMT2A (0.86) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17719221 0.79 KMT2A (0.78) SMN1; SMN2KMT2ALMNAMEN1TDP1
SCHEMBL17719212 0.76 KMT2A (0.79) SMN1; SMN2KMT2ALMNAMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273954-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE UNIVERSITY OF CHICAGO (US) 2017-09-28 — — US disclosed
US-9675592-B2 Methods and compositions for bacteria infections THE UNIVERSITY OF CHICAGO (US) 2017-06-13 — — US disclosed
US-20160120852-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF ILLINOIS (US) 2016-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273954-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS SPOUT1, OXA1L, VSIR SMN1; SMN2 1662/4885KMT2A 809/4885LMNA 1893/4885
US-20160120852-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS SPOUT1, OXA1L, VSIR SMN1; SMN2 1662/4885KMT2A 809/4885LMNA 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback